Review of osteoimmunology and the host response in endodontic and periodontal lesions

Journal of Oral Microbiology

Volumn 3, Issue 2011, 2011, Pages

  Graves, Dana T ^a   Oates, Thomas ^b   Garlet, Gustavo P ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bacteria; Bone; Chemokine; Cytokine; Endodontic lesion; Gingivitis; Inflammation; Periodontitis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GINGIVITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; MONOCYTE; NONHUMAN; OSTEOLYSIS; PATHOGENESIS; PERIODONTAL DISEASE; POLYMORPHONUCLEAR CELL; PORPHYROMONAS GINGIVALIS; REVIEW; SIGNAL TRANSDUCTION; TOOTH DISEASE; UPREGULATION;

EID: 84863989927     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v3i0.5304     Document Type: Review

References (124)

1. Kakehashi S, Stanley HR, Fitzgerald RJ. The effects of surgical exposures of dental pulps in germ-free and conventional laboratory rats. Oral Surg Oral Med Oral Pathol 1965; 20: 340-9.
2. Ricucci D, Siqueira JF Jr, Bate AL, Pitt Ford TR. Histologic investigation of root canal-treated teeth with apical periodontitis: a retrospective study from twenty-four patients. J Endod 2009; 35: 493-502.
3. Nair PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 2004; 15: 348-81.
4. Liapatas S, Nakou M, Rontogianni D. Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J 2003; 36: 464-71.
5. Stashenko P, Wang C, Riley E, Wu Y, Ostroff G, Niederman R. Reduction of infection-stimulated peripical bone resorption by the biological response modifier PGG glucan. J Dent Res 1995; 74: 323-30.
6. Graves D, Chen C, Douville C, Jiang Y. Interleukin-1 receptor signaling rather than that of tumor necrosis factor is critical in protecting the host from the severe consequences of a polymicrobe anaerobic infection. Infect Immun 2000; 8: 4746-51.
7. Fukada SY, Silva TA, Saconato IF, Garlet GP, Avila-Campos MJ, Silva JS, et al. iNOS-derived nitric oxide modulates infection-stimulated bone loss. J Dent Res 2008; 87: 1155-9.
8. Jiang Y, Mehta C, Hsu T, Alsulaimani F. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 2002; 70: 3143-8.
9. Gilles J, Carnes D, Dallas M, Holt S, Bonewald L. Oral bone loss is increased in ovariectomized rats. J Endodon 1997; 23: 419-22.
10. Hirao K, Yumoto H, Takahashi K, Mukai K, Nakanishi T, Matsuo T. Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. J Dent Res 2009; 88: 762-7.
11. Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 2008; 41: 195-203.
12. Stashenko P, Yu SM, Wang CY. Kinetics of immune cell and bone resorptive responses to endodontic infections. J Endod 1992; 18: 422-6.
13. Colic M, Gazivoda D, Vucevic D, Vasilijic S, Rudolf R, Lukic A. Proinflammatory and immunoregulatory mechanisms in periapical lesions. Mol Immunol 2009; 47: 101-13.
14. Fukada SY, Silva TA, Garlet GP, Rosa AL, da Silva JS, Cunha FQ. Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases. Oral Microbiol Immunol 2009; 24: 25-31.
15. Colic M, Gazivoda D, Vucevic D, Majstorovic I, Vasilijic S, Rudolf R, et al. Regulatory T-cells in periapical lesions. J Dent Res 2009; 88: 997-1002.
16. Teles R, Wang CY, Stashenko P. Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections. Infect Immun 1997; 65: 3781-7.
17. Tani N, Kuchiba K, Osada T, Watanabe Y, Umemoto T. Effect of T-cell deficiency on the formation of periapical lesions in mice: histological comparison between periapical lesion formation in BALB/c and BALB/c nu/nu mice. J Endod 1995; 21: 195-9.
18. Wallstrom JB, Torabinejad M, Kettering J, McMillan P. Role of T cells in the pathogenesis of periapical lesions. A preliminary report. Oral Surg Oral Med Oral Pathol 1993; 76: 213-8.
19. De Rossi A, Rocha LB, Rossi MA. Interferon-gamma, interleukin-10, intercellular adhesion molecule-1, and chemokine receptor 5, but not interleukin-4, attenuate the development of periapical lesions. J Endod 2008; 34: 31-8.
20. Menezes R, Garlet TP, Trombone AP, Repeke CE, Letra A, Granjeiro JM, et al. The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis. J Endod 2008; 34: 1480-4.
21. Alshwaimi E, Purcell P, Kawai T, Sasaki H, Oukka M, Campos-Neto A, et al. Regulatory T cells in mouse periapical lesions. J Endod 2009; 35: 1229-33.
22. McNicholas S, Torabinejad M, Blankenship J, Bakland L. The concentration of prostaglandin E2 in human periradicular lesions. J Endod 1991; 17: 97-100.
23. Torbinejad M, Clagett J, Engel D. A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin. Calcif Tissue Int 1979; 29: 207-14.
24. Fouad AF. IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice. J Dent Res 1997; 76: 1548-54.
25. Tani-Ishii N, Wang CY, Stashenko P. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. Oral Microbiol Immunol 1995; 10: 213-9.
26. Stashenko P, Wang CY, Tani-Ishii N, Yu SM. Pathogenesis of induced rat periapical lesions. Oral Surg Oral Med Oral Pathol 1994; 78: 494-502.
27. Wang C, Stashenko P. The role of interleukin-1 alpha in the pathogenesis of periapical bone destruction in a rat model system. Oral Microbiol Immunol 1993; 8: 50-6.
28. Takeichi O, Saito I, Tsurumachi T, Moro I, Saito T. Expression of inflammatory cytokine genes in vivo by human alveolar bone-derived polymorphonuclear leukocytes isolated from chronically inflamed sites of bone resorption. Calcif Tissue Int 1996; 58: 244-8.
29. Walker KF, Lappin DF, Takahashi K, Hope J, Macdonald DG, Kinane DF. Cytokine expression in periapical granulation tissue as assessed by immunohistochemistry. Eur J Oral Sci 2000; 108: 195-201.
30. Huang GT, Do M, Wingard M, Park JS, Chugal N. Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 83-8.
31. Yamasaki M, Kumazawa M, Kohsaka T, Nakamura H. Effect of methodtrexate-induced neutropenia on rat periapical lesion. Oral Surg Oral Med Oral Pathol 1994; 77: 655-61.
32. Huang GT, Potente AP, Kim JW, Chugal N, Zhang X. Increased interleukin-8 expression in inflamed human dental pulps. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 214-20.
33. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007; 86: 306-19.
34. Rahimi P, Wang C, Stashenko P, Lee S, Lorenzo J, Graves D. Monocyte chemoattractant prtein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology 1995; 136: 2752-9.
35. Chae P, Im M, Gibson F, Jiang Y, Graves D. Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment. Infect Immun 2002; 70: 3164-9.
36. Garlet TP, Fukada SY, Saconato IF, Avila-Campos MJ, Silva TAD, Garlet GP, et al. CCR2 deficiency results in increased osteolysis in experimental periapical lesions in mice. J Endod 2010; 36: 244-50.
37. Menezes R, Garlet TP, Letra A, Bramante CM, Campanelli AP, Figueira Rde C, et al. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. J Endod 2008; 34: 932-8.
38. Kawashima N, Suzuki N, Yang G, Ohi C, Okuhara S, Nakano-Kawanishi H, et al. Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 707-11.
39. Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006; 42: 80-7.
40. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366: 1809-20.
41. Sakamoto M, Umeda M, Benno Y. Molecular analysis of human oral microbiota. J Periodontal Res 2005; 40: 277-85.
42. Haffajee AD, Teles RP, Socransky SS. The effect of periodontal therapy on the composition of the subgingival microbiota. Periodontol 2000 2006; 42: 219-58.
43. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000 2006; 42: 114-57.
44. Assuma R, Oates T, Cochran D, Amar S, Graves D. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998; 160: 403-9.
45. Delima A, Spyros K, Amar S, Graves DT. Inflammation and tissue loss caused by periodontal pathogens is reduced by IL-1 antagonists. J Infect Dis 2002; 186: 511-6.
46. Teng Y, Nguyen H, Gao X, Kong Y, Gorczynski R, Singh B et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000; 106: R59-67.
47. Baker P, Dixon M, Evans R, Dufour L, Johnson E, Roopenian D. CD4(-) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999; 67: 2804-9.
48. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol 1984; 11: 21-32.
49. Cohen ME, Ralls SA. Distributions of periodontal attachment levels. Mathematical models and implications. J Periodontol 1988; 59: 254-8.
50. Gilthorpe MS, Zamzuri AT, Griffiths GS, Maddick IH, Eaton KA, Johnson NW. Unification of the "burst" and "linear" theories of periodontal disease progression: a multilevel manifestation of the same phenomenon. J Dent Res 2003; 82: 200-5.
51. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 2008; 35: 89-105.
52. Rovin S, Costich ER, Gordon HA. The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J Periodontal Res 1966; 1: 193-204.
53. Mahanonda R, Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 2007; 43: 41-55.
54. Gelani V, Fernandes AP, Gasparoto TH, Garlet TP, Cestari TM, Lima HR, et al. The role of toll-like receptor 2 in the recognition of Aggregatibacter actinomycetemcomitans. J Periodontol 2009; 80: 2010-9.
55. Lima HR, Gelani V, Fernandes AP, Gasparoto TH, Torres SA, Santos CF, et al. The essential role of TLR4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. J Clin Periodontol 2010; 37: 248-54.
56. Uehara A, Takada H. Functional TLRs and NODs in human gingival fibroblasts. J Dent Res 2007; 86: 249-54.
57. Williams R, Jeffcoat M, Kaplan M, Goldhaber P, Johnson H, Wechter W. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 1985; 227: 640-2.
58. Delima A, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001; 28: 233-40.
59. Han X, Kawai T, Eastcott JW, Taubman MA. Bacterialresponsive B lymphocytes induce periodontal bone resorption. J Immunol 2006; 176: 625-31.
60. Jin Q, Cirelli JA, Park CH, Sugai JV, Taba M Jr, Kostenuik PJ, et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007; 78: 1300-8.
61. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008; 79: 1585-91.
62. Fracon RN, Teofilo JM, Satin RB, Lamano T. Prostaglandins and bone: potential risks and benefits related to the use of nonsteroidal anti-inflammatory drugs in clinical dentistry. J Oral Sci 2008; 50: 247-52.
63. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 2007; 43: 85-101.
64. Miyauchi M, Ijuhin N, Nikai H, Takata T, Ito H, Ogawa I. Effect of exogenously applied prostaglandin E2 on alveolar bone loss-histometric analysis. J Periodontol 1992; 63: 405-11.
65. Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000; 39: 4761-8.
66. Bezerra MM, de Lima V, Alencar VB, Vieira IB, Brito GA, Ribeiro RA, et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000; 71: 1009-14.
67. Pinho Mde N, Pereira LB, de Souza SL, Palioto DB, Grisi MF, Novaes AB Jr, et al. Short-term effect of COX-2 selective inhibitor as an adjunct for the treatment of periodontal disease: a clinical double-blind study in humans. Braz Dent J 2008; 19: 323-8.
68. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2006; 20: 401-3.
69. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006; 21: 12-20.
70. Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin-1beta, clinical parameters and matched cellularhistopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res 2003; 38: 247-54.
71. Salvi GE, Brown CE, Fujihashi K, Kiyono H, Smith FW, Beck JD, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 1998; 33: 212-25.
72. Stashenko P, Jandinski J, Fujiyoshi P, Rynar J, Socransky S. Tissue levels of bone resorptive cytokines in periodontal disease. J Perio 1991; 62: 504-9.
73. Chiang C, Kyritsis G, Graves D, Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 1999; 67: 4231-6.
74. Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, et al. In vivo administration of IL-1 beta accelerates silk ligatureinduced alveolar bone resorption in rats. J Oral Pathol Med 1995; 24: 420-34.
75. Dayan S, Stashenko P, Niederman R, Kupper TS. Oral epithelial overexpression of IL-1alpha causes periodontal disease. J Dent Res 2004; 83: 786-90.
76. Kurtis B, Tuter G, Serdar M, Akdemir P, Uygur C, Firatli E et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005; 76: 1849-55.
77. Bostrom L, Linder L, Bergstrom J. Clinical expression of TNFalpha in smoking-associated periodontal disease. J Clin Periodontol 1998; 25: 767-73.
78. Lee HJ, Kang IK, Chung CP, Choi SM. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol 1995; 22: 885-90.
79. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003; 38: 198-203.
80. Graves D, Oskoui M, Volejnikova S, Naguib G, Cai S, Desta T, et al. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 2001; 80: 1875-9.
81. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol 2007; 147: 128-38.
82. Liu R, Desta T, Raptis M, Darveau RP, Graves DT. P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J Periodontol 2008; 79: 1241-7.
83. Graves D, Liu R, Alikhani M, Al-Mashat H, Trackman P. Diabetes-enhanced inflammation and apoptosis - impact on periodontal pathology. J Dent Res 2006; 85f: 15-21.
84. Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res 2000; 79: 1548-55.
85. Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM, et al. Actinobacillus actinomycetemcomitans lipopolysac-charide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol 2007; 78: 550-8.
86. Page R, Schroeder H. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976; 34: 235-49.
87. Aggarwal R, Ghobrial IM, Roodman GD. Chemokines in multiple myeloma. Exp Hematol 2006; 34: 1289-95.
88. Tsai CC, Ho YP, Chen CC. Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 1995; 66: 852-9.
89. Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001; 125: 134-41.
90. Alnaeeli M, Park J, Mahamed D, Penninger JM, Teng YT. Dendritic cells at the osteo-immune interface: implications for inflammation-induced bone loss. J Bone Miner Res 2007; 22: 775-80.
91. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci 2009; 14: 540-51.
92. Zhang X, Teng YT. Interleukin-10 inhibits gram-negativemicrobe-specific human receptor activator of NF-kappaB ligand-positive CD4-Th1-cell-associated alveolar bone loss in vivo. Infect Immun 2006; 74: 4927-31.
93. Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, et al. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 2004; 180: 193-201.
94. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Murakami K, Miyake Y, et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol 2005; 141: 467-74.
95. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 2001; 36: 194-203.
96. Garlet G, Martins W Jr, Ferreira B, Milanezi C, Silva J. Patterns of chemokine and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003; 38: 210-7.
97. Hanazawa S, Kawata Y, Takeshita A, Kumada H, Okithu M, Tanaka S, et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993; 61: 5219-24.
98. Yu X, Graves D. Fibroblasts, mononuclear phagocytes and endothelial cells express MCP-1 in inflamed human gingiva. J Periodontol 1995; 66: 80-8.
99. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006; 169: 987-98.
100. Teng YT, Mahamed D, Singh B. Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL-CD4-Th-cell-mediated alveolar bone destruction in vivo. Infect Immun 2005; 73: 3453-61.
101. Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003; 23: 147-61.
102. Eastcott JW, Yamashita K, Taubman MA, Harada Y, Smith DJ. Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiol Immunol 1994; 9: 284-9.
103. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/ Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004; 35: 21-41.
104. Kantarci A, Oyaizu K, Van Dyke TE. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol 2003; 74: 66-75.
105. Dennison DK, Van Dyke TE. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 1997; 14: 54-78.
106. Garlet GP, Cardoso CR, Campanelli AP, Garlet TP, Avila-Campos MJ, Cunha FQ, et al. The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect 2008; 10: 489-96.
107. Lee W, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res 1995; 30: 23-33.
108. Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 2009; 31: 377-88.
109. Vernal R, Leon R, Herrera D, Garcia-Sanz JA, Silva A, Sanz M. Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J Periodontal Res 2008; 43: 689-97.
110. Jotwani R, Cutler CW. Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response. Infect Immun 2004; 72: 1725-32.
111. Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005; 32: 57-71.
112. Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci 2008; 1143: 123-50.
113. Alnaeeli M, Penninger JM, Teng YT. Immune interactions with CD4- T cells promote the development of functional osteoclasts from murine CD11c- dendritic cells. J Immunol 2006; 177: 3314-26.
114. Baker P, Evans R, Roopenian D. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 1994; 39: 1035-40.
115. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-98.
116. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB, et al. An essential role for IL-17 in preventing pathogeninitiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007; 109: 3794-802.
117. Cardoso CR, Garlet GP, Crippa GE, Rosa AL, Junior WM, Rossi MA, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009; 24: 1-6.
118. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8: 523-32.
119. Cardoso CR, Garlet GP, Moreira AP, Junior WM, Rossi MA, Silva JS. Characterization of CD4- CD25- natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol 2008; 84: 311-8.
120. Ernst CW, Lee JE, Nakanishi T, Karimbux NY, Rezende TM, Stashenko P, et al. Diminished forkhead box P3/CD25 doublepositive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL-) T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol 2007; 148: 271-80.
121. Nakajima T, Ueki-Maruyama K, Oda T, Ohsawa Y, Ito H, Seymour GJ, et al. Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res 2005; 84: 639-43.
122. Parfitt A. The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res 1982; 4: 1-6.
123. Behl Y, Siqueira M, Ortiz J, Li J, Desta T, Faibish D, et al. Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol 2008; 181: 8711-8.
124. Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 2006; 85: 510-4.